Both in Biotechnology
Protalix BioTherapeutics vs Palisade Bio
Over the past year PLX returned +13.8% and PALI returned −37.3%; their daily moves had a correlation of 0.10.
PLX +13.8% PALI −37.3%Growth of $1, one year, split-adjusted
| Metric | PLX | PALI |
|---|---|---|
| Price | $2.72 | $1.26 |
| Market cap | $219.2M | $218.7M |
| Today | +4.21% | +2.03% |
| 1 month | −0.4% | −15.8% |
| 6 months | +34.7% | −37.3% |
| Year to date | +51.1% | −46.6% |
| 1 year | +13.8% | −37.3% |
| Revenue growth (YoY) | +27.1% | — |
| Gross margin | 61.0% | 100.0% |
| Net margin | 19.0% | −2114.8% |
| P/E (TTM) | 11.6× | — |
| Price / sales | 2.7× | 437.4× |
| Net cash | $40.7M | $125.2M |
| Dividend yield | — | — |
| Volatility (60d) | 45.3% | 78.3% |
| Short % of float | 4.7% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).